Pharmacoeconomic analysis of various adjunctive pharmacotherapy strategies for back pain using comparative method
Spinal disorders are one of the leading causes of disability worldwide. Back pain is one of the most important factors that reduce the patients’ quality of life. The right choice of pharmacotherapy in conjunction with other medical technologies is the key to successful treatment. In addition to drug...
Main Author: | P. A. Balunov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2018-04-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/2371 |
Similar Items
-
A new look at back pain treatment in light of the latest ESCEO guidelines
by: O. A. Shavlovskaya, et al.
Published: (2020-12-01) -
Prescription of chondroitin sulfate in back pains
by: O. A. Shavlovskaya, et al.
Published: (2020-01-01) -
Experience with the use of chondroitin sulfate for pain in the back
by: O. A. Shavlovskaya, et al.
Published: (2020-12-01) -
The use of chondroitin sulfate (Mucosat) for the treatment of chronic back pain and osteoarthritis
by: O. A. Shavlovskaya, et al.
Published: (2020-03-01) -
Pharmacoeconomic analysis of the use of movalis (meloxicam) in patients with nonspecific back pain
by: O. N. Gerasimova, et al.
Published: (2011-12-01)